An official website of the United States government.
Date posted
Funding Agency
(Funded by the National Institutes of Health)
Researchers from the University of Connecticut are collaborating to develop novel asthma therapeutics using gene-silencing nanocapsules in a bid to help patients who aren't benefiting from existing treatments. The nucleic acid nanocapsule is designed to selectively deliver an enzyme to silence a component of the immune response that leads to the over-expression of immune components that play a significant role in allergic asthma attacks.
